You searched for "Optics"
Ocular sequalae of spinal muscular atrophy
he authors present a retrospective single-centre cohort study of patients with spinal muscular atrophy – a neurodegenerative disorder presenting between infancy and early adulthood. Forty-eight patients were included in total, with roughly equal numbers of types 1, 2 and 3...
Visual characteristics of spina bifida myelomeningocele
Ireland has a relatively high rate of spina bifida (SB), with a neural tube defect rate of 1.05 per 1000 births of which 47% are SB. This study was an audit of SB myelomeningocele (SBM) cases over an 8-year period,...CPD education sessions now live for 100% Optical and 100% Ophthalmology
Organisers of the UK’s largest optical show, 100% Optical have announced that its first batch of CPD education programme sessions have launched with the second phase set to go live in the weeks to come. With a promise to ‘focus...Artificial intelligence in glaucoma: Assessing applications instead of technology
Much is said about the potential of artificial intelligence (AI) to transform clinical practice, particularly with the advent of foundation models [1]. The newest models are ‘pretrained’ on text, image, tabular and other forms of data to produce architectures that...AOP fee reduction for members amidst coronavirus crisis
The Association of Optometrists (AOP) has announced a 20% reduction in membership fees for UK practising members, which is the equivalent of two monthly direct debit payments.SightCare 'The Future is Now' Conference a Success
SightCare, the business support community for independent practices, was held on 29 and 30 January 2023 after its postponement from its original September date which unfortunately fell on the day of the Queen’s funeral.Optical Express sponsors Atlantic rowing challenge for dementia research
Optical Express has become the official headline sponsor of a rowing challenge that will see Jason Black (52) and Neil Glover (60) row over 3100 miles across the Atlantic Ocean, in an effort to raise money to fund groundbreaking research into a cure for dementia.
